🇺🇸 FDA

Company profile · Sponsor

60

60 DEGREES PHARMACEUTICALS, INC.

SXTP · NYSE pharma WASHINGTON, DC, USA
Pipeline
5
Drugs
0
Patents
0

Quick answer

60 (SXTP) is a pharma company. headquartered in WASHINGTON, DC, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker SXTP
Exchange NYSE
Company type pharma
Headquarters WASHINGTON, DC, USA
SEC CIK 0001946563

Pipeline (5)

Search pipeline →

  1. Celgosivir

    60

    Dengue Fever

    phase 2 small molecule terminated

    1 trial

  2. Tafenoquine

    60

    Babesiosis

    phase 2 small molecule active

    1 trial

  3. Tafenoquine

    60

    Healthy Volunteers

    phase 2 small molecule completed

    1 trial

  4. Tafenoquine 100mg

    60

    Chronic Babesiosis

    phase 2 small molecule active

    1 trial

  5. Tafenoquine Oral Tablet

    60

    COVID 19 Disease

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is 60?

60 (SXTP) is a pharma company. headquartered in WASHINGTON, DC, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does 60 sponsor?

We track 5 ClinicalTrials.gov-linked programs for 60, including Celgosivir and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does 60 company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.